Search for Clinical Trials

A multicenter, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of ecopipam in…
  • Neurovascular
The purpose of this study is to find out how safe and effective the new drug, AMX0035, is for the treatment of PSP and to determine if AMX0035 can…
  • Neurovascular
A multicenter, open-label, study to evaluate the longterm safety of ecopipam tablets in children, adolescents and adults with Tourette's disorderThe…
  • Neurovascular
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's diseaseThe purpose of this study…
  • Neurovascular
A 17-Week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, multicenter study of the efficacy and safety of…
  • Neurovascular
An open-label study of the long-term safety and tolerability of Sage-324 in participants with essential tremorThe purpose of this study is to…
  • Neurovascular
Sage Therapeutics, Inc. is sponsoring this study of an investigational drug called SAGE-718.  SAGE-718 is being evaluated for possible…
  • Neurovascular
This is a research study being conducted by Dr. Chi-Ying (Roy) Lin through the Baylor College of Medicine, under the funding of CurePSP.Being in this…
  • Neurovascular
Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
  • Neurovascular
The Relight clinical research study is currently testing an investigational medication for people living with depression, or Major Depressive…
  • Women's Health
  • Depression and Mood Disorders
  • Men's Health
  • Psychiatry and Behavior
Back to topback-to-top